Learn More
Medchemexpress LLC 4-chloro-1-piperidin-4-yl-N-(5-pyridin-2-yl-1H-pyrazol-4-yl)pyrazole-3-carboxamide | 1817698-21-7 | MFCD28386213 | >98.0% | 371.8 g/mol | C17H18ClN7O | 50MG

Supplier: Medchemexpress LLC HY1243750MG
BDP5290 is a small-molecule kinase inhibitor selective for Rho-associated kinases (ROCK) and myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK). It is used as a research reagent in biochemical and cell-based assays to probe pathways controlling myosin light chain phosphorylation, cell motility, and tumor cell invasion.
- Potent inhibition of ROCK1 (IC50 5 nM), ROCK2 (IC50 50 nM), MRCKα (IC50 10 nM), and MRCKβ (IC50 100 nM).
- High reported purity: >98.0%.
- Molecular formula C17H18ClN7O and molecular weight 371.8 g/mol.
- Suitable for in vitro and cell-based research applications investigating cytoskeletal regulation.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.